A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kasper Kyhl1,2*, MD; Jacob Lønborg1, MD, PhD; Niels Vejlstrup1, MD, PhD; Henning Kelbæk1, MD, DMSc; Steffen Helqvist1, MD, DMSc; Lene Holmvang1, MD, DMSc; Erik Jørgensen1, MD; Kari Saunamäki1, MD, DMSc; Hans Erik Bøtker3, MD, PhD, DMSc; Peter Clemmensen1, MD, DMSc; Lars Køber1, MD, PhD, DMSc; Marek Treiman2, MD, DMSc; Thomas Engstrøm1, MD, PhD, DMSc